Effect of EGFR and p-AKT Overexpression on Chromosomal Instability in Gastric Cancer

This publication has 31 references indexed in Scilit:

• A phase 1 study evaluating the combination of an allosteric AKT inhibitor (MK-2206) and trastuzumab in patients with HER2-positive solid tumors
  Breast Cancer Research, 2013
• HER2 in gastric cancer: a digital image analysis in pre-neoplastic, primary and metastatic lesions
  Laboratory Investigation, 2013
• Genomic instability and oncogene amplifications in colorectal adenomas predict recurrence and synchronous carcinoma
  Laboratory Investigation, 2011
• Profiling signalling pathways in formalin‐fixed and paraffin‐embedded breast cancer tissues reveals cross‐talk between EGFR, HER2, HER3 and uPAR
  Journal of Cellular Physiology, 2011
• The PI3K–Akt mediates oncogenic Met-induced centrosome amplification and chromosome instability
  Carcinogenesis, 2010
• Biomarker analysis in stage III–IV (M0) gastric cancer patients who received curative surgery followed by adjuvant 5-fluorouracil and cisplatin chemotherapy: epidermal growth factor receptor (EGFR) associated with favourable survival
  British Journal of Cancer, 2009
• EGFRvIII expression and PTEN loss synergistically induce chromosomal instability and glial tumors
  Neuro-Oncology, 2009
• Prognostic Significance of Epidermal Growth Factor Receptor Expression in Colon Cancer Patients Undergoing Curative Surgery
  Annals of Surgical Oncology, 2006
• Akt phosphorylation associates with LOH of PTEN and leads to chemoresistance for gastric cancer
  International Journal of Cancer, 2005
• Augmentation of a humanized Anti-HER2 mAb 4D5 induced growth inhibition by a human-mouse chimeric anti-EGF receptor mAb C225
  Oncogene, 1999